glp-1 drugs compounding pharmacy Managing Compounded Medications: A Pharmacist's Guide for Employers – Sequoia As GLP-1 weight-loss drugs surged

Reddy IA, Pino JA, Weikop P, Osses N, Srensen G, Bering T, et al

This substantial inventory build signals management's confidence in regulatory approval and represents a decisive effort to avoid repeating the supply constraints that plagued earlier product rollouts [4]

In this study, a large portion of patients reported multiple discontinuation reasons, reflecting the multifaceted challenges involved in GLP-1 RA use including tolerability, cost, access, and individual treatment goals

Johri N et al

However, for patients with chronic kidney disease (CKD) , these medications require careful dosing to avoid risks like dehydration, electrolyte imbalances, and acute kidney injury

In a twist, the study found that although there was a small increase in diabetic retinopathy, GLP-1 use appeared to protect against the conditions progression and sight-threatening complications